Psychiatry · Wilmington, DE
NPI
1649300179
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
3521 Silverside Rd, Quillen 2c
Wilmington, DE, 19810
Phone (302) 529-5760
Medicare paid, 2024
$171K
3,109 services
Medicare patients, 2024
397
Average age 73
Drug cost, 2024
$579K
5,482 prescriptions
Company payments, 2025
$714
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathlyn L Rowen was code 99213 (office e&m - established), 1,539 times for 392 patients. In total Kathlyn L Rowen billed 3,109 services in 3 codes, and Medicare paid $171K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,539 | 392 | $60.31 | $93K |
| 90833 Psychotherapy - Nongroup | Office | 1,538 | 392 | $48.25 | $74K |
| 90792 Psychotherapy - Nongroup | Office | 32 | 32 | $128.50 | $4,112 |
By year: 2022 $179K for 3,067 services; 2023 $148K for 2,637 services; 2024 $171K for 3,109 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathlyn L Rowen prescribed most often to Medicare patients was Escitalopram Oxalate, with 450 prescriptions and refills. In total Kathlyn L Rowen wrote 5,482 Medicare prescriptions that cost $579K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Escitalopram Oxalate Generic | 450 | 1,094 | 103 | $9,010 |
| Clonazepam Generic | 367 | 483 | 59 | $3,195 |
| Bupropion Xl Bupropion Hcl | 365 | 879 | 89 | $11K |
| Lamotrigine Generic | 340 | 823 | 76 | $6,075 |
| Trazodone Hcl Generic | 326 | 580 | 75 | $2,799 |
| Fluoxetine Hcl Generic | 292 | 661 | 59 | $4,820 |
| Alprazolam Generic | 266 | 331 | 62 | $2,146 |
| Sertraline Hcl Generic | 255 | 606 | 61 | $2,608 |
| Quetiapine Fumarate Generic | 238 | 506 | 43 | $6,975 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 203 | 205 | 22 | $6,426 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 187 | 400 | 31 | $4,594 |
| Duloxetine Hcl Generic | 157 | 325 | 36 | $5,238 |
| Lorazepam Generic | 155 | 199 | 30 | $1,560 |
| Buspirone Hcl Generic | 139 | 231 | 37 | $2,191 |
| Mirtazapine Generic | 128 | 224 | 31 | $3,730 |
Brand drugs: 276 claims; generic drugs: 5,206 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathlyn L Rowen $714 ($714 in general payments such as food, travel and fees) from 9 companies. The largest payer was Neurocrine BioSciences, Inc. with $199.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 4 | $199 |
| Bausch Health US, LLC BHC | 13 | $174 |
| Alkermes, Inc. ALKS | 3 | $83.74 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $62.4 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $55.74 |
| Abbvie Inc. ABBV | 2 | $51.23 |
| Axsome Therapeutics, Inc. AXSM | 2 | $38.84 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $31.89 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $16.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.